Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SWX/GALD stock hub

SWX/GALD has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SWX/GALDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

38.4B

SIX Swiss Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SWX/GALD

In the news

Latest news · SWX/GALD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E45.9

P25 15.9P50 20.7P75 33.1

Trailing P/E80.1

P25 19.6P50 21.4P75 37.6

ROE7.7

P25 -6.1P50 7.9P75 17

ROIC8.4

P25 -4.4P50 6.6P75 15.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SWX/GALD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

217

Groups with data

Currency

USD

Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	CH
Employees	7,676
Employees Change	1,131%
Employees Change Percent	17.28
Enterprise value	CHF 40B
Exchange	SIX Swiss Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CH1335392721
Last refreshed	2026-05-10
Market cap	CHF 38.4B
Price	CHF 164
Price currency	CHF
Rev Per Employee	541,408.41x
Sector	Healthcare
Sic	2834
Symbol	swx/GALD
Website	https://www.galderma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.26%
EV Earnings	82.31x
EV/EBIT	57.02x
EV/EBITDA	43.09x
EV/FCF	47.07x
EV/Sales	9.63x
FCF yield	2.21%
Forward P/E	45.89x
P/B ratio	5.95x
P/E ratio	80.11x
P/S ratio	9.25x
PE Ratio3 Y	108.93x
PEG ratio	1.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.89%
EBITDA Margin	21.64%
FCF margin	20.45%
Gross margin	68.86%
Gross Profit	CHF 2.9B
Gross Profit Growth	11.18%
Gross Profit Growth Q	23.63%
Gross Profit Growth3 Y	6.32%
Gross Profit Growth5 Y	8.4%
Net Income	CHF 486.1M
Net Income Growth	165.37%
Net Income Growth Q	127.72%
Net Income Growth Quarters	6%
Net Income Growth Years	4%
Pretax Margin	12.19%
Profit Margin	11.7%
Profit Per Employee	CHF 63,324
Profitable Years	2
ROA	4.25
ROCE	7.81
ROE	7.69
ROIC	8.39
Roic5y	-2.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	69.22%
EPS Growth	166
EPS Growth Q	129.1
EPS Growth Quarters	6
EPS Growth Years	4
FCF Growth	197.78%
FCF Growth Q	67.86%
FCF Growth3 Y	59.74%
FCF Growth5 Y	49.03%
OCF Growth	142.83%
OCF Growth Q	58.5%
OCF Growth3 Y	41.42%
OCF Growth5 Y	43.36%
Revenue Growth	18.04x
Revenue Growth Q	24.78x
Revenue Growth Quarters	3x
Revenue Growth Years	4x
Revenue Growth3 Y	6.67x
Revenue Growth5 Y	8.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.4
Assets	CHF 10.6B
Cash	CHF 618.5M
Current Assets	CHF 1.9B
Current Liabilities	CHF 1.6B
Debt	CHF 2.2B
Debt EBITDA	CHF 2.35
Debt Equity	CHF 0.34
Debt FCF	CHF 2.57
Equity	CHF 6.5B
Interest Coverage	5.12
Liabilities	CHF 4.2B
Long Term Assets	CHF 8.7B
Long Term Liabilities	CHF 2.6B
Net Cash	CHF -1.6B
Net Cash By Market Cap	CHF -4.07
Net Debt EBITDA	CHF 1.74
Net Debt Equity	CHF 0.24
Net Debt FCF	CHF 1.84
Tangible Book Value	CHF -1.3B
Tangible Book Value Per Share	CHF -5.47
WACC	4.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.19
Inventory Turnover	3.52
Net Working Capital	CHF -264.1M
Quick ratio	0.9
Working Capital	CHF 302.9M
Working Capital Turnover	CHF 11.92

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.34%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	CHF 0.35
Dividend Years	2
Dividend Yield	0.21%
Ex Div Date	2026-04-24
Last Dividend	CHF 0.35
Payout Frequency	Annual
Payout Ratio	6.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	69.16%
200-day SMA	148.3
50-day SMA	153.5
50-day SMA vs 200-day SMA	50over200
All Time High	171.9
All Time High Change	-4.65%
All Time High Date	2026-05-07
All Time Low	60
All Time Low Change	173.17%
All Time Low Date	2024-03-22
ATR	4.44
Beta	-0.05
Beta1y	0.35
Beta2y	0.55
Ch YTD	1.11
High	167.2
High52	171.9
High52 Date	2026-05-07
High52ch	-4.65%
Low	163.9
Low52	96.5
Low52 Date	2025-05-08
Low52ch	69.85%
Ma50ch	6.79%
Price vs 200-day SMA	10.53%
RSI	56.42
RSI Monthly	76.81
RSI Weekly	60.33
Sharpe ratio	1.77x
Sortino ratio	3.09
Total Return	0.55%
Tr YTD	1.33
Tr1m	7.43%
Tr1w	-0.15%
Tr3m	11.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 701.8M
Operating Income Growth	18.47
Operating Income Growth Q	38.76
Operating Income Growth3 Y	12.29
Operating Income Growth5 Y	20.42
Operating margin	16.89

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	96,818,495%
Net Borrowing	-227,647,815
Shares Institutions	31.77%
Shares Out	234,568,725
Shares Qo Q	-0.6%
Shares Yo Y	-0.34%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF 799.3M
Average Volume	460,041.2x
Bv Per Share	27.55
CAPEX	CHF -89.6M
Ch1m	7.19
Ch1w	-0.15
Ch1y	68.8
Ch3m	11.73
Ch6m	14.06
Change	-2.15%
Change From Open	-1.06
Close	167.5
Days Gap	-1.1
Depreciation Amortization	193,461,795
Dollar Volume	55,216,271
Earnings Date	2026-07-23
EBIT	CHF 701.8M
EBITDA	CHF 899.2M
EPS	CHF 2.05
F Score	7
FCF	CHF 850M
FCF EV Yield	2.12x
FCF Per Share	CHF 3.62
Financing CF	-577,267,600
Fiscal Year End	December
Founded	1,981
Goodwill	3,985,002,195
Graham Number	35.83846
Graham Upside	-78.13
Income Tax	CHF 20.6M
Investing CF	-122,114,300
Is Primary Listing	1
Last Earnings Date	2026-03-05
Last Report Date	2025-12-31
Ma150	152.3
Ma150ch	7.62%
Ma20	160
Ma20ch	2.46%
Net CF	256,122,850
Next Earnings Date	2026-07-23
Open	165.7
P FCF Ratio	45.23
P OCF Ratio	40.92
Payment Date	2026-04-28
Position In Range	0
Ppne	578,054,520
Price Date	2026-05-08
Price EBITDA	CHF 42.76
Relative Volume	0.73x
Revenue	4,155,850,950x
SBC By Revenue	1.22x
Share Based Comp	50,748,800
Tax By Revenue	0.5x
Tax Rate	4.07%
Tr6m	14.31%
Volume	336,890
Z Score	5.36

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SWX/GALD dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.2%

$0.35 annual per share

Payout ratio

+6.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+0.5%

Next ex-dividend date: 2026-04-24

Performance

SWX/GALD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SWX/GALD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+31.8%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.3%

Negative means the company is buying back shares.

Technical

SWX/GALD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.4

Neutral momentum band

Price vs 200-day MA

+10.5%

50/200-day relationship not available

Beta (5Y)

-0.05

Less volatile than the market

Sharpe ratio

1.77

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SWX/GALD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current swx/GALD stock rating?

swx/GALD is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full swx/GALD analysis?

The full report lives at /stocks/swx/GALD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for swx/GALD?

The latest report frames swx/GALD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the swx/GALD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.